arrow
B

Beatrice Detti

azienda usl centro toscana
H指数:30
被引数:3,118

个人简介

暂无内容

教育背景

暂无内容

工作经历

暂无内容

荣誉奖项

暂无内容

The Evolving Landscape of Novel and Old Biomarkers in Localized High-Risk Prostate Cancer: State of the Art, Clinical Utility, and Limitations Toward Precision Oncology

新型与旧型生物标志物在局部高危前列腺癌中的演变格局:精准肿瘤学背景下的现状、临床应用与局限性

2025-08-120
OA
Current diagnostic and therapeutic options in de novo low-volume metastatic hormone-sensitive prostate cancer

当前对于新发低体积转移性激素敏感性前列腺癌的诊断和治疗选择

2025-05-210
PRE
Hypofractionated radiotherapy in elderly patients (≥75 years) affected by localized prostate cancer: a multicenter retrospective analysis from the IPOPROMISE study
2025-03-010
PRE
Results of Stereotactic Body Radiation Therapy for Primary Renal Cell Carcinoma in a Large Multicenter Series

立体定向体部放射治疗在大型多中心系列中对于原发性肾细胞癌的治疗结果

2025-02-010
PRE
Image-guided moderately hypofractionated radiotherapy for localized prostate cancer: a multicentric retrospective study (IPOPROMISE)
2024-02-192
OAAI
Stereotactic reirradiation with CyberknifeR for locally recurrent prostate cancer, long-term toxicity and clinical outcomes from a monocentric cohort
2023-09-201
PRE
Prostatectomy Bed Image-guided Dose-escalated Salvage Radiotherapy (SPIDER): An International Multicenter Retrospective Study
2023-08-0112
PRE
Salvage Stereotactic Reirradiation for Local Recurrence in the Prostatic Bed After Prostatectomy: A Retrospective Multicenter Study

前列腺切除术后前列腺床局部复发的挽救性立体定向再照射: 一项回顾性多中心研究

2023-06-016
OA
Early biochemical outcomes following PSMA guided approach for bIoCHEmical relapse after prostatectomy-PSICHE trial (NCT05022914): preliminary results

PSMA指导前列腺切除术后生化复发的早期生化结果-PSICHE试验 (NCT05022914): 初步结果

2023-04-036
OAAI
Choline PET/CT in recurrent prostate cancer
2023-03-213
OAAI
Predictive factors for tolerance to taxane based chemotherapy in older adults affected by metastatic prostate cancer (ANCHISES-NCT05471427): A prospective observational trial including patients with metastatic hormone sensitive and castrate resistant prostate cancer treated with taxane chemotherapy
2023-01-015
PRE
Study protocol and preliminary results from a mono-centric cohort within a trial testing stereotactic body radiotherapy and abiraterone (ARTO-NCT03449719)
2022-06-287
OAAI
Accelerated hypofractionated radiation for elderly or frail patients with a newly diagnosed glioblastoma: A pooled analysis of patient-level data from 4 prospective trials
CANCER
IF5.1
2022-03-229
OAAI
Stereotactic or conventional radiotherapy for macroscopic prostate bed recurrence: a propensity score analysis
2022-03-0513
OAAI